Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing
Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5